JP2023011549A5 - - Google Patents

Download PDF

Info

Publication number
JP2023011549A5
JP2023011549A5 JP2022143256A JP2022143256A JP2023011549A5 JP 2023011549 A5 JP2023011549 A5 JP 2023011549A5 JP 2022143256 A JP2022143256 A JP 2022143256A JP 2022143256 A JP2022143256 A JP 2022143256A JP 2023011549 A5 JP2023011549 A5 JP 2023011549A5
Authority
JP
Japan
Prior art keywords
medicament according
salt
compound
dose
cell proliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022143256A
Other languages
English (en)
Japanese (ja)
Other versions
JP7420888B2 (ja
JP2023011549A (ja
Filing date
Publication date
Priority claimed from JP2018216023A external-priority patent/JP7140645B2/ja
Application filed filed Critical
Publication of JP2023011549A publication Critical patent/JP2023011549A/ja
Publication of JP2023011549A5 publication Critical patent/JP2023011549A5/ja
Priority to JP2024002690A priority Critical patent/JP2024056686A/ja
Application granted granted Critical
Publication of JP7420888B2 publication Critical patent/JP7420888B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022143256A 2017-11-16 2022-09-08 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬 Active JP7420888B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024002690A JP2024056686A (ja) 2017-11-16 2024-01-11 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2018560956 2017-11-16
JP2018560956 2017-11-16
JP2020571576 2018-05-16
JP2020571576 2018-05-16
JP2018216023A JP7140645B2 (ja) 2017-11-16 2018-11-16 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018216023A Division JP7140645B2 (ja) 2017-11-16 2018-11-16 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024002690A Division JP2024056686A (ja) 2017-11-16 2024-01-11 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Publications (3)

Publication Number Publication Date
JP2023011549A JP2023011549A (ja) 2023-01-24
JP2023011549A5 true JP2023011549A5 (ru) 2023-07-27
JP7420888B2 JP7420888B2 (ja) 2024-01-26

Family

ID=76321132

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018216023A Active JP7140645B2 (ja) 2017-11-16 2018-11-16 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬
JP2022143256A Active JP7420888B2 (ja) 2017-11-16 2022-09-08 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬
JP2024002690A Pending JP2024056686A (ja) 2017-11-16 2024-01-11 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018216023A Active JP7140645B2 (ja) 2017-11-16 2018-11-16 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024002690A Pending JP2024056686A (ja) 2017-11-16 2024-01-11 クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Country Status (1)

Country Link
JP (3) JP7140645B2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7140645B2 (ja) 2017-11-16 2022-09-21 ジ インスティテュート オブ キャンサー リサーチ:ロイヤル キャンサー ホスピタル クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059339A1 (es) * 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
JP7140645B2 (ja) 2017-11-16 2022-09-21 ジ インスティテュート オブ キャンサー リサーチ:ロイヤル キャンサー ホスピタル クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬

Similar Documents

Publication Publication Date Title
CA2856646C (en) Combination treatment of cancer
JP2019536805A5 (ru)
CA2672000A1 (en) Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
JP2017537126A5 (ru)
JP2018507243A5 (ru)
JP2006513184A5 (ru)
JP2019521988A5 (ru)
JP2021509395A5 (ru)
JP2018503610A5 (ru)
JP2019516684A5 (ru)
JP2021152002A5 (ru)
KR20180016350A (ko) 구역과 구토를 치료하기 위한 아미설프리드 및 추가의 구토 방지제의 병용
JP2023011549A5 (ru)
JP2019524888A5 (ru)
JP2017508737A5 (ru)
JP2024056686A (ja) クマリン誘導体を含有する、細胞増殖性疾患の治療又は予防用医薬
JPWO2019241442A5 (ru)
JP2010504307A5 (ru)
JPWO2020118252A5 (ru)
JP2021091608A5 (ru)
JPWO2019226761A5 (ru)
JP2020523317A5 (ru)
TW201244732A (en) Ezatiostat for treating multiple myeloma
EP3010508B1 (en) Combination of ro5503781, capecitabine and oxaliplatin for cancer therapy
JP2012031141A (ja) 骨髄異形性症候群を治療するための組成物および方法